We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
3176
DELISTED
Whitestone REIT
WSR
$3K ﹤0.01%
212
-6,878
-97% -$86.2K
WTTR icon
3177
Select Water Solutions
WTTR
$2.61B
$3K ﹤0.01%
+300
New +$3.5K
XIN
3178
DELISTED
Xinyuan Real Estate
XIN
$3K ﹤0.01%
83
+38
+84% +$1.71K
QVCGA
3179
DELISTED
QVC Group Inc Series A
QVCGA
$3K ﹤0.01%
5
-7
-58% -$4.99K
SYRS
3180
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3K ﹤0.01%
+28
New +$1.95K
INFN
3181
DELISTED
Infinera Corporation Common Stock
INFN
$3K ﹤0.01%
948
+748
+374% +$2.81K
GHSI
3182
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$3K ﹤0.01%
+8
New +$4.71K
NTG
3183
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$3K ﹤0.01%
19
-8
-30% -$1.11K
AEL
3184
DELISTED
American Equity Investment Life Holding Company
AEL
$3K ﹤0.01%
101
-43
-30% -$1.23K
TRHC
3185
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3K ﹤0.01%
+68
New +$3.38K
RETA
3186
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3K ﹤0.01%
+32
New +$2.76K
BBIG
3187
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$3K ﹤0.01%
+97
New +$4.93K
VRAY
3188
DELISTED
ViewRay, Inc.
VRAY
$3K ﹤0.01%
395
-3,358
-89% -$27.3K
NMTR
3189
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
+130
New +$3.9K
BICK
3190
DELISTED
First Trust BICK Index Fund
BICK
$3K ﹤0.01%
118
-252
-68% -$6.72K
DCP
3191
DELISTED
DCP Midstream, LP
DCP
$3K ﹤0.01%
91
-229
-72% -$7.15K
AGRX
3192
DELISTED
Agile Therapeutics
AGRX
$3K ﹤0.01%
+1
New +$2.79K
ASAP
3193
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$3K ﹤0.01%
22
-3
-12% -$512
NH
3194
DELISTED
NantHealth, Inc
NH
$3K ﹤0.01%
349
+58
+20% +$590
IBMK
3195
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$3K ﹤0.01%
100
TGA
3196
DELISTED
Transglobe Energy Corp
TGA
$3K ﹤0.01%
1,710
+961
+128% +$1.62K
TMX
3197
DELISTED
Terminix Global Holdings, Inc.
TMX
$3K ﹤0.01%
57
-5,815
-99% -$299K
ALNA
3198
DELISTED
Allena Pharmaceuticals
ALNA
$3K ﹤0.01%
+839
New +$4.58K
AUTO
3199
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$3K ﹤0.01%
720
-1,473
-67% -$5.09K
PTE
3200
DELISTED
PolarityTE, Inc. Common Stock
PTE
$3K ﹤0.01%
18
-69
-79% -$13.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.